ImmunoGen Inc (IMGN)

[skitahoe]

You may very well be right, but even the Institutions need something positive to build the price when they push to do so. I believe the Phase 3 data clearly indicated that with the proper target the drug will easily be approved. I'm hoping a partnership well before that time will answer all questions about future funding, and drugs beyond IMGN853 will also be nearing approval.

This company still has the potential of exceeding SGEN's market cap, but it needs one or more of it's own drugs to be approved. While European approval is still a possibility, the FDA remains the gold standard, and clearly that will be a few years.

Gary